Becton, Dickinson and Co. | BDX - Pre Tax Profit




Becton, Dickinson and Co. reported $2B in Pre-Tax Profit for its fiscal quarter ending in September of 2024.

Pre Tax Profit Change Date
Abbott USD 2.03B 90M Dec/2024
Agilent USD 468M 125M Oct/2024
Align Technology USD 165.93M 22.06M Sep/2024
Avanos Medical USD 9.5M 3.3M Sep/2024
Baxter International USD 69M 326M Sep/2024
Becton, Dickinson and Co. USD 2B 1.5B Sep/2024
Bio-Rad Laboratories USD 861.62M 3.65B Sep/2024
Boston Scientific USD 668M 248M Sep/2024
Cooper Companies USD 168.6M 61.6M Oct/2024
Danaher USD 1.51B 427M Sep/2024
Dentsply International USD -478000000 512M Sep/2024
Dexcom USD 177.4M 10.4M Sep/2024
Edwards Lifesciences USD 402.8M 16.2M Sep/2024
Exact Sciences USD -37428000 23.09M Sep/2024
Globus Medical USD 57.03M 9.45M Sep/2024
Hologic USD 295.8M 55.1M Sep/2024
Insulet USD 82.9M 31.8M Sep/2024
Integra LifeSciences USD -20362000 5.18M Sep/2024
Intuitive Surgical USD 671M 16.5M Sep/2024
J&J USD 3.89B 0 Dec/2024
Masimo USD 48.7M 28.8M Sep/2024
Medtronic USD 2B 70M Oct/2024
Patterson Companies USD 35.54M 3K Oct/2024
Solventum Corp 367M 59M Sep/2024
Stryker USD 1.04B 45M Sep/2024
Tandem Diabetes Care USD -22614000 7.13M Sep/2024
Teleflex USD 189.7M 92.2M Sep/2024
Terumo JPY 39.51B 6.13B Sep/2024
Thermo Fisher Scientific USD 1.73B 47M Sep/2024
Zimmer Biomet Holdings USD 230.3M 71.9M Sep/2024